Scarica l'app Stockscreener
1.48
1.37%
0.02
Dopo l'orario di chiusura:
1.50
0.02
+1.35%
Precedente Chiudi:
$1.46
Aprire:
$1.46
Volume 24 ore:
96,253
Relative Volume:
0.32
Capitalizzazione di mercato:
$8.08M
Reddito:
-
Utile/perdita netta:
$-6.91M
Rapporto P/E:
-0.454
EPS:
-3.26
Flusso di cassa netto:
$-6.14M
1 W Prestazione:
+8.03%
1M Prestazione:
-29.19%
6M Prestazione:
-43.51%
1 anno Prestazione:
-57.25%
Intervallo 1D:
$1.4001
$1.52
Intervallo di 1 settimana:
$1.3218
$1.5383
Portata 52W:
$1.15
$23.80
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
Nome
Galmed Pharmaceuticals Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Confronta GLMD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
1.48 | 7.97M | 0 | -6.91M | -6.14M | -3.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2020-05-22 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2020-02-04 | Iniziato | Craig Hallum | Buy |
| 2020-01-30 | Ripresa | Cantor Fitzgerald | Overweight |
| 2019-12-02 | Iniziato | Canaccord Genuity | Buy |
| 2018-12-12 | Iniziato | B. Riley FBR | Buy |
| 2018-08-02 | Reiterato | Maxim Group | Buy |
| 2018-07-13 | Iniziato | Stifel | Buy |
| 2018-07-12 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-06-12 | Reiterato | H.C. Wainwright | Buy |
| 2018-03-15 | Aggiornamento | Maxim Group | Hold → Buy |
| 2018-02-14 | Downgrade | Maxim Group | Buy → Hold |
| 2018-02-12 | Reiterato | H.C. Wainwright | Buy |
| 2017-11-15 | Iniziato | ROTH Capital | Buy |
| 2017-08-08 | Reiterato | H.C. Wainwright | Buy |
| 2017-07-31 | Reiterato | Maxim Group | Buy |
| 2016-08-01 | Reiterato | Maxim Group | Buy |
| 2016-07-06 | Ripresa | ROTH Capital | Buy |
| 2016-03-28 | Ripresa | H.C. Wainwright | Buy |
| 2015-06-23 | Iniziato | H.C. Wainwright | Buy |
| 2015-05-06 | Iniziato | Sun Trust Rbsn Humphrey | Buy |
Mostra tutto
Galmed Pharmaceuticals Ltd Borsa (GLMD) Ultime notizie
Galmed Pharmaceuticals Reschedules Shareholder Meeting Due to Lack of Quorum - TipRanks
What machine learning models say about Galmed Pharmaceuticals Ltd.Weekly Investment Recap & Fast Moving Market Watchlists - Newser
Why Galmed Pharmaceuticals Ltd. is moving today2025 Major Catalysts & Smart Money Movement Alerts - Newser
How Galmed Pharmaceuticals Ltd. stock performs during market volatilityTrade Volume Report & Scalable Portfolio Growth Methods - Newser
Volatility clustering patterns for Galmed Pharmaceuticals Ltd.Layoff News & Weekly Momentum Stock Picks - Newser
Analyzing Galmed Pharmaceuticals Ltd. with multi timeframe charts2025 Growth vs Value & Technical Pattern Recognition Alerts - Newser
What’s next for Galmed Pharmaceuticals Ltd. stock priceWeekly Loss Report & Technical Analysis for Trade Confirmation - Newser
Can Galmed Pharmaceuticals Ltd. hit a new high this monthWeekly Market Outlook & Daily Volume Surge Trade Alerts - Newser
Historical volatility pattern of Galmed Pharmaceuticals Ltd. visualized2025 Technical Overview & Stock Portfolio Risk Management - Newser
Is Galmed Pharmaceuticals Ltd. Stock a Good Fit for Conservative InvestorsChart Pattern Strategy with ROI Focus - Newser
Is Galmed Pharmaceuticals Ltd. showing signs of accumulationFree Stock Screener With Smart Filters - Newser
How to recover losses in Galmed Pharmaceuticals Ltd. stockDaily Technical Chart Pattern Analysis Report - Newser
Galmed Pharmaceuticals (NASDAQ:GLMD) Raised to Hold at Wall Street Zen - Defense World
Is Galmed Pharmaceuticals Ltd. still worth holding after the dipDaily Pattern Analysis with Return Forecast - Newser
Short Interest in Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Expands By 49.9% - Defense World
Quantitative breakdown of Galmed Pharmaceuticals Ltd. recent moveVolume Spike Detection for Early Breakouts - Newser
What moving averages say about Galmed Pharmaceuticals Ltd.Swing Trade Watchlist with Entry Zones - Newser
Short Term Trend Reversal in Galmed Pharmaceuticals Ltd. PossibleHigh Accuracy Alerts for ROI Traders Detected - beatles.ru
Technical signs of recovery in Galmed Pharmaceuticals Ltd.High Conviction Stock Long-Term Summary - Newser
Investors Hope for Bounce in Galmed Pharmaceuticals Ltd. After Selloff - metal.it
Why Galmed Pharmaceuticals Ltd. stock attracts strong analyst attentionNear-Term Market Opportunity Forecast Sheet - Newser
Is it the right time to buy Galmed Pharmaceuticals Ltd. stockMaximize returns with strategic portfolio planning - Jammu Links News
How does Galmed Pharmaceuticals Ltd. compare to its industry peersHigh-octane financial growth - Jammu Links News
What is Galmed Pharmaceuticals Ltd. company’s growth strategyConsistently outstanding ROI - Jammu Links News
What are Galmed Pharmaceuticals Ltd. company’s key revenue driversMaximize portfolio value with expert tips - Jammu Links News
Is Galmed Pharmaceuticals Ltd. stock overvalued or undervaluedAccelerated wealth expansion - Jammu Links News
What drives Galmed Pharmaceuticals Ltd. stock priceUnlock daily stock market insights for success - Jammu Links News
Is Galmed Pharmaceuticals Ltd. a good long term investmentUnmatched profit potential - Jammu Links News
Should I hold or sell Galmed Pharmaceuticals Ltd. stock in 2025Accelerated financial growth - Jammu Links News
What are analysts’ price targets for Galmed Pharmaceuticals Ltd. in the next 12 monthsAccess high-quality stock research instantly - Jammu Links News
What is the risk reward ratio of investing in Galmed Pharmaceuticals Ltd. stockUnmatched market performance - Jammu Links News
Why is Galmed Pharmaceuticals Ltd. stock attracting strong analyst attentionFree Expert Stock Watchlist - Jammu Links News
When is Galmed Pharmaceuticals Ltd. stock expected to show significant growthBuild a winning investment portfolio - Jammu Links News
Identifying reversal signals in Galmed Pharmaceuticals Ltd.Deep Learning Stock Forecast for Investors - Newser
What catalysts could drive Galmed Pharmaceuticals Ltd. stock higher in 2025Exceptional gains - Jammu Links News
Galmed Pharmaceuticals (NASDAQ:GLMD) Cut to Sell at Wall Street Zen - Defense World
What are the technical indicators suggesting about Galmed Pharmaceuticals Ltd.Achieve breakthrough financial results - Jammu Links News
Galmed Pharmaceuticals Ltd Azioni (GLMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):